This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Factors Contributing to Its Mortality, Palliation, and Cure

Thomas G. Magill, MD; Richard L. Simmons, MD

AMA Arch Surg. 1967;94(6):865-870.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CARCINOMA of the esophagogastric junction is recognized as an entity which carries a poor prognosis. The operative treatment in this area is a procedure of considerable magnitude associated with a relatively high mortality and complication rate.^1-5 The cure rate as judged by five-year survival ranges from 7.5%⁶ to 17%⁵ in the larger reported series. There has been some controversy as to the reported difference of survival with primary esophageal lesions in contrast to those arising in the cardia.^7-10 Surgeons and radiotherapists generally agree that resection is the treatment of choice for carcinoma of this region.¹¹

Since the five-year survival rate is so poor, the major problem which faces the surgeon is the degree of palliation which can be offered the patient who presents with progressive and intractable dysphagia. The three major modalities available for palliation of this distressing symptom are resection, radiotherapy, and insertion of . . . [Full Text PDF of this Article]

Author Affiliations
New York

From the Columbia-Presbyterian Medical Center, New York.

Footnotes
Submitted for publication Dec 10, 1966.

Reprint requests to Columbia-Presbyterian Medical Center, 622 W 168th St, New York 10032 (Dr. Magill).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?